Clinical Accelerator
Clinical Accelerator is a sponsor-aligned CRO that runs First-in-Human and Early Feasibility clinical trials for early-stage medical device companies, delivering in Eastern Europe and Central Asia with a cardiovascular KOL network and a lean, flat delivery model.
- Company typePrivate
- Founded-
- HeadquartersDouglas
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Clinical Accelerator does
Clinical Accelerator is a privately held, sponsor-aligned Contract Research Organization (CRO) that runs First-in-Human (FIH) and Early Human Feasibility medical device clinical trials for early-stage MedTech companies. It is headquartered in Douglas, Isle of Man, with its primary operational hub in Tbilisi, Georgia and additional country operations in Uzbekistan and Lithuania/EU. Its offering combines full-service clinical trial management — regulatory liaison, site coordination, feasibility leadership, and trial operations — with a proprietary SMPEO operating methodology, a trusted network of high-performing clinical sites across Eastern Europe and Central Asia, and an academic advisory network of cardiovascular key opinion leaders who also serve as proctors and operators. The firm also operates ecosystem assets: the annual Georgia MedTech Innovation Summit (GMIS) in Tbilisi and the associated GMIS Shark Tank pitch competition ($25,000 grand prize). Its named client base spans cardiovascular (structural heart, heart failure, mechanical circulatory support, AAA, renal denervation), oncology device, renal/wearable diagnostics, and biotech indications, with clients drawn primarily from US, Europe, Australia, Israel, and Asia.
The commercial model is professional services: quote-based, multi-year CRO contracts priced per study rather than per modular component, with prospects entering through feasibility calls to the Head of Business Development. Pricing is not publicly disclosed. Go-to-market is sales-led and direct, leveraging content marketing (blog, YouTube, LinkedIn), events (GMIS, Shark Tank), and referral/community channels cultivated through the KOL and advisory network. The company is founder-controlled (Nikolay Nikitin, Founder & CEO) with a flat organizational structure of approximately 50 clinical research professionals, no disclosed external investors, and no public revenue or funding figures.
Strategic positioning targets the specific pain points of early-stage device programs — unpredictable enrollment, slow site activation, expensive study budgets, regulatory burden, and CRO-layer overhead — by combining lean delivery in lower-cost jurisdictions with academic-grade clinical expertise in cardiovascular medicine.
Clinical Accelerator firmographics
Firmographics- Name
- Clinical Accelerator
- Legal name
- Clinical Accelerator
- Website
- https://clinicalaccelerator.com
- Company type
- Private
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Clinical Accelerator is a sponsor-aligned CRO that runs First-in-Human and Early Feasibility clinical trials for early-stage medical device companies, delivering in Eastern Europe and Central Asia with a cardiovascular KOL network and a lean, flat delivery model.
- Ownership category
- akta.pro rank
Clinical Accelerator industry classification
Industry- Product category
- Contract Research Organization (CRO) Services for Medical Devices
- NAICS
- Scientific Research and Development Services (5417)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Clinical CROs (Phase I–IV) (HLAGAAAA)
- akta.pro secondary industries
- Patient Recruitment, Site Feasibility & Trial Enablement CROs (HLAGAAAI), Clinical Trial Site Operations & Study Coordination (HLAGACAE)
Keywords
Where Clinical Accelerator is headquartered
LocationHeadquarters
- HQ city
- Douglas
Offices4 records
Markets served
Clinical Accelerator business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Others
Revenue model
- CRO Services - Clinical Trial Management: Full-service CRO offering for First-in-Human and early feasibility medical device studies. Provides regulatory liaison, site coordination, and trial operations management. Revenue generated through professional services contracts with MedTech sponsors.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Custom CRO service contracts for early-stage medical device trials |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels6 records
Clinical Accelerator product offering
Product offeringCore offering
Clinical Accelerator is a sponsor-aligned Contract Research Organization (CRO) specializing in First-in-Human (FIH) and Early Human Feasibility (EFS) medical device clinical trials. It delivers full-service trial operations — regulatory liaison, site coordination, feasibility leadership, enrollment management, and monitoring — for MedTech sponsors, executing studies in Eastern Europe and Central Asia. Service delivery is anchored by the proprietary SMPEO operational methodology, a Trusted Site Network, and an Academic KOL Advisory Network.
Product overview
Clinical Accelerator is a Sponsor-Aligned CRO (Contract Research Organization) specializing in First-in-Human and Early Human Feasibility medical device studies. The company operates as a unified service offering rather than a modular software platform, combining its SMPEO operational methodology with a dedicated site network across Eastern Europe and Central Asia, an academic and KOL advisory network, the Georgia MedTech Innovation Summit (GMIS) annual event, and the GMIS Shark Tank pitch competition. The core service offering is augmented by feasibility consultation services and advisory board expertise to deliver fast startup, efficient enrollment, and high-quality clinical data.
Differentiator
Problem solved
Functional benefit
Products and services
- Clinical Trial Management Services Full-service CRO offering operational management for First-in-Human and Early Human Feasibility medical device studies, including regulatory liaison, site coordination, feasibility leadership, and trial operations. Target customers are MedTech sponsors globally.
- Georgia MedTech Innovation Summit (GMIS) Annual invitation-only summit in Tbilisi, Georgia bringing together physicians, clinical KOLs, MedTech industry leaders, investors, and R&D experts to highlight advancements in cardiovascular and interventional medicine.
- GMIS Shark Tank Competition
Quantifiable outcome
- Trusted by 100+ MedTech clients globally
- +1 more outcomes
Companies that use Clinical Accelerator
Customer profileNamed customers16 records
Segments3 records
Ideal customer profiles3 records
Clinical Accelerator technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Clinical Accelerator partnerships and signals
Strategic signalPartnerships
Nine partnerships are on record, tiered core and minor.
- HEPTA MedicalcoreClinical Accelerator supports HEPTA Medical in execution and operational management of early-stage clinical trials evaluating the safety and performance of their innovative microwave ablation platform with in-situ patented tissue temperature sensor and proprietary predictive software for real-time monitoring and control of ablation procedures in early-stage cancer treatment.
- Magenta MedicalcoreClinical Accelerator supports the ELEVATE IV First-in-Human study for Magenta Medical's Elevate pLVAD delivering >5.4 L/min mean flow and >8.4 L/min peak flow for cardiogenic shock patients. Georgian investigators at Healthycore Clinic successfully completed this advanced mechanical circulatory support investigation.
- AngiolutionscoreClinical Accelerator partners with Angiolutions to accelerate their early clinical development program for the A3-Shield implant, the first-of-its-kind device designed to stop progression of abdominal aortic aneurysms (AAA) based on pioneering research from Stanford University.
- Relief CardiovascularcoreClinical Accelerator acts as CRO for Relief Cardiovascular's FIH trial of the Relief System, the world's first transcatheter smart implant that dynamically monitors and modulates cardiac preload and congestion in chronic heart failure patients. Full study approval granted in Georgia.
- Sutra MedicalcoreClinical Accelerator partners with Sutra Medical to support early clinical development of the Sutra Hemi-Valve TMVR system, a unique approach that replaces only the posterior leaflet while preserving native valve anatomy and eliminating LVOT obstruction risk.
- Gradient Denervation TechnologiescoreClinical Accelerator supported Gradient Denervation Technologies' first-in-human study for their ultrasound-based pulmonary artery denervation system targeting pulmonary hypertension secondary to left heart disease. Study successfully launched in Georgia.
- Polares MedicalcoreOver three years of collaboration with Polares Medical advancing early-stage clinical investigations of the PLAR (Posterior Leaflet Augmentation and Replacement) system for mitral valve therapy. Clinical Accelerator managed early feasibility studies in Georgia, validating clinical potential and laying foundation for pivotal studies.
- Proton IntelligencecoreClinical Accelerator collaborates with Proton Intelligence on early human feasibility study in dialysis patients for the world's first real-time, on-demand potassium monitoring wearable to prevent hyperkalemia and hypokalemia in CKD and CHF patients, under leadership of Dr. Marat Fudim at Duke University.
- Nyra MedicalminorNyra Medical participated in EuroPCR meeting presenting clinical insights from First-in-Human study of the CARLEN System for treating functional mitral regurgitation, with two sessions sponsored by Clinical Accelerator.
Scale indicators3 records
Recent moves6 records
Expansion highlights5 records
Clinical Accelerator competitors and assessment
Company assessmentDirect peers
- Biorasi: Biorasi is a mid-sized, sponsor-aligned CRO with early-phase and specialty therapeutic capabilities serving emerging biotech and MedTech companies. Its customer profile and operational model closely mirror Clinical Accelerator's positioning.
- Celerion: Celerion is a specialized early-phase clinical research provider with strong First-in-Human experience, particularly in cardiovascular and metabolic indications. It competes directly with Clinical Accelerator for FIH/EFS contracts from MedTech and biotech sponsors.
- Premier Research: Premier Research is a specialty CRO with strong medical device, rare disease, and early-phase capabilities serving small and mid-sized biotech/MedTech sponsors. It is comparable in customer profile and service scope to Clinical Accelerator.
- NAMSA: NAMSA is the largest global CRO dedicated exclusively to medical devices, with deep FIH and Early Feasibility Study experience and a similar focus on helping MedTech sponsors navigate regulatory and clinical execution. It is the most directly comparable pure-play device CRO to Clinical Accelerator in scope and customer type.
- CATO SMS: CATO SMS is an early-phase-focused CRO with strong First-in-Human expertise, particularly in complex and specialty indications. It competes for FIH/EFS mandates similar to those Clinical Accelerator targets.
- BBK Worldwide: BBK Worldwide is a patient recruitment and clinical trial enrollment specialist. Its focus on enrollment acceleration and feasibility is directly comparable to Clinical Accelerator's SMPEO model and trusted site network.
- Clinipace Worldwide (now Ceva Clinical): Clinipace/Ceva Clinical is a mid-sized, technology-enabled CRO serving emerging and mid-market biotech/MedTech sponsors. Its mid-market focus and adaptive service model are comparable to Clinical Accelerator's lean, sponsor-aligned approach.
Broad incumbents
- IQVIA: IQVIA is the world's largest CRO with broad medical device, FIH, and feasibility study capabilities. It serves as a scale-driven incumbent alternative for MedTech sponsors considering Clinical Accelerator for early-stage work.
- Medpace: Medpace is a mid-to-large full-service CRO with a meaningful medical device and early-phase practice, serving biotech and MedTech sponsors globally. It represents the broad incumbent alternative that sponsors may compare Clinical Accelerator against for FIH/EFS engagements.
- Worldwide Clinical Trials: Worldwide Clinical Trials is a mid-sized full-service CRO with cardiovascular and early-phase experience. It serves as a comparable alternative for sponsors evaluating FIH/EFS MedTech programs.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
Clinical Accelerator social profiles
Digital presenceClinical Accelerator financial estimates
Financial estimateRevenue estimate
Valuation estimate
Clinical Accelerator leadership team
Management profileNumber of profiles
Profiles6 records
Clinical Accelerator funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Clinical Accelerator M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Clinical Accelerator
What does Clinical Accelerator do?
Clinical Accelerator is a sponsor-aligned Contract Research Organization (CRO) specializing in First-in-Human (FIH) and Early Human Feasibility (EFS) medical device clinical trials. It delivers full-service trial operations — regulatory liaison, site coordination, feasibility leadership, enrollment management, and monitoring — for MedTech sponsors, executing studies in Eastern Europe and Central Asia. Service delivery is anchored by the proprietary SMPEO operational methodology, a Trusted Site Network, and an Academic KOL Advisory Network.
Is Clinical Accelerator a public or private company?
Clinical Accelerator is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Clinical Accelerator founded?
Clinical Accelerator was founded in -1. It employs 11 to 50 people.
Where is Clinical Accelerator based?
Clinical Accelerator is headquartered in Douglas.
How does Clinical Accelerator make money?
One revenue line is on record: CRO Services - Clinical Trial Management.
Who are Clinical Accelerator's main competitors?
Direct peers on record are Biorasi, Celerion, Premier Research, NAMSA, CATO SMS, BBK Worldwide and Clinipace Worldwide (now Ceva Clinical). Broad incumbents are IQVIA, Medpace and Worldwide Clinical Trials.
Does Clinical Accelerator have an API?
No public API is recorded for Clinical Accelerator.
What industry is Clinical Accelerator in?
Clinical Accelerator's product category is Contract Research Organization (CRO) Services for Medical Devices. Its primary akta.pro industry code is HLAGAAAA, Clinical CROs (Phase I–IV), with a secondary code of HLAGAAAI, Patient Recruitment, Site Feasibility & Trial Enablement CROs. Its NAICS code is 5417 and its SIC code is 8731.